Skip to content

HKPD.HK

Cellyan Biotechnology Ltd.

Healthcare · Medical - Pharmaceuticals · HK

Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue33.7M13.4M20.3M16.7M12.6M
Cost of Revenue29.9M12.0M17.9M13.1M9.8M
Gross Profit3.8M1.4M2.4M3.6M2.7M
Operating Expenses
R&D Expense
SG&A Expense4.6M2.4M2.2M1.9M1.8M
General & Admin Expense
Selling & Marketing Expense
Other Expenses53.4K(13.9K)67.3K60.9K(62.9K)
Total Operating Expenses4.7M2.4M2.3M2.0M1.7M
Cost and Expenses34.6M14.4M20.2M15.1M11.5M
Operating Income (EBIT)(862.9K)(994.9K)132.0K1.6M1.0M
Non-Operating
Interest Income1.7K474.00219.00
Interest Expense229.3K133.4K97.7K82.8K23.2K
Net Interest Income(229.3K)(133.4K)(95.9K)(82.3K)(23.0K)
Other Non-Op Income/Expense(229.3K)(133.4K)(95.9K)(82.3K)(23.0K)
Non-Operating Income (excl Interest)(48.2K)10.0K(1.7K)(474.00)(219.00)
EBT (Pre-Tax Income)(1.1M)(1.1M)36.1K1.5M1.0M
Income Tax Expense245.1K7.7K63.2K196.3K22.6K
Bottom Line
Net Income(1.2M)(1.1M)(27.1K)1.3M998.2K
Earnings from Cont. Ops(1.3M)(1.1M)(27.1K)1.3M998.2K
Earnings from Discont. Ops
Bottom Line Net Income(1.2M)(1.1M)(27.1K)1.3M998.2K
Per Share
Basic EPS($0.02)($0.05)($0.00)$0.18$0.09
Diluted EPS($0.02)($0.05)($0.00)$0.18$0.09
Revenue Per Share$0.94$0.57$2.25$2.27$1.14
Shares
Basic Shares Outstanding36.0M23.5M9.0M7.4M11.0M
Diluted Shares Outstanding36.0M23.5M10.2M7.4M11.0M
Profitability Metrics
EBITDA(652.4K)(918.4K)1.2M2.5M1.8M
D&A162.3K86.5K1.1M925.6K714.6K
EBIT(814.7K)(1.0M)133.8K1.6M1.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026